A New Porous Cadmium(Ⅱ) Complex Based on 1,10-Phenanthroline Derivative and Dicarboxylate:Syntheses,Structure, Thermal Behavior and Luminescence

A new porous Cd(Ⅱ) coordination compound, namely, [Cd(bpdc)(L)2]·3H2O(1, L = 11-fluoro-dipyrido[3,2-a:2,3-c]phenazine and bpdc = 1,1-biphenyl-2,2-dicarboxylate) was synthesized under hydrothermal conditions, and characterized by single-crystal X-ray diffraction. It crystallizes in tetragonal, space group P4122 with a = 9.8486(4), b = 9.8486(4), c = 45.925(4)A, V = 4454.5(5) 3, Z = 4, C50H29 Cd F2N8O7, Mr = 1004.21, Dc = 1.497 g/cm3, F(000) = 2028, μ(Mo Ka) = 0.562 mm-1, R = 0.0566 and w R = 0.1585. Each Cd(Ⅱ) atom is coordinated by one bpdc anion and two L ligands to give a discrete molecule. Neighboring discrete molecules are stacked by π-π interactions among L ligands, resulting in an interesting 1D supramolecular chain. Moreover, the 1D supramolecular chains are packed with each other to give a porous structure, in which an infinite channel is filled with water molecules. In addition, the thermal behavior and luminescent property of 1 have also been studied.     

2-去氢表雄酮苯亚甲基衍生物的合成及抗炎活性研究

阿尔茨海默症作为21世纪全球主要健康危机之一,由于其发病机制的复杂性,目前还未找到很好的解决办法.为了找到更加经济有效的治疗神经退行性疾病的药物,合成了一系列新型2-去氢表雄酮苯亚甲基衍生物,并研究了其对脂多糖(LPS)激活小胶质细胞株BV-2 NO释放及细胞存活率的影响.结果表明所合成化合物作用24 h后,对LPS活化的小鼠小胶质细胞株BV2的NO释放均有不同程度的抑制作用,且具有一定的浓度依赖性.活性最好的化合物15β,16β-亚甲基雄甾-2-(3-氯)-苯亚甲基-4,6-二烯-3,17-二酮(5a)和15β,16β-亚甲基雄甾-2-(3,4,5-三甲氧基)-苯亚甲基-4,6-二烯-3,17-二酮(5j)的IC_(50)值分别为2.69和3.28μmol·L~(-1),优于阳性对照米诺环素.此类化合物在涉及活化小胶质细胞的神经退行性疾病方面的作用值得进一步研究.